[144] Vor Biopharma Inc. SEC Filing

Rhea-AI Filing Summary

On 08/01/2025, GATX Corporation (GATX) director Shelley J. Bausch reported the acquisition of 158 restricted stock units (RSUs) under the company’s Amended and Restated Directors’ Voluntary Deferred Fee Plan. The RSUs were credited in lieu of cash board fees and through dividend reinvestment at an effective price of $152.825 per share. Each RSU converts to one share of common stock upon settlement, generally after the director leaves the board.

After the transaction, Bausch’s direct beneficial ownership rises to 3,015 shares. No shares were sold and no derivative securities were involved. Because the award stems from routine deferred-compensation elections rather than an open-market purchase, the immediate market impact is expected to be minimal.

Insights

Financial Analyst

TL;DR: Small, routine RSU grant; signals continued alignment but immaterial to valuation.

The filing shows a non-market award of 158 RSUs to director Shelley Bausch via the deferred fee plan, lifting her stake to 3,015 shares. At roughly $24k in notional value, the grant is negligible versus GATX’s market cap and daily volume, so price impact should be insignificant. Nonetheless, ongoing insider accumulation—albeit automatic—maintains board-management alignment with shareholders. No red flags, no dilution, and no change to strategic outlook; overall neutral.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	29432	61589.40	124959520	08/04/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/04/2025	Exercised Shares	Issuer			29432	08/04/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many GATX shares did director Shelley J. Bausch acquire on 08/01/2025?

She acquired 158 restricted stock units representing the right to receive an equal number of common shares.

What was the effective price for the RSUs credited to Shelley J. Bausch?

The RSUs were valued at $152.825 per share under the deferred fee plan.

How many GATX shares does Shelley J. Bausch own after the transaction?

Her direct beneficial ownership increased to 3,015 shares of common stock.

Did the Form 4 include any dispositions or derivative transactions?

No. The filing shows only an acquisition of RSUs; no shares were sold and no derivatives were reported.

What plan facilitated the RSU grant to the GATX director?

The grant was made under the Amended and Restated GATX Corporation Directors’ Voluntary Deferred Fee Plan.